Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the bioequivalence (equivalence of pharmacokinetic
parameters) of 2 abiraterone acetate coated tablet formulations with respect to the current
commercial abiraterone acetate uncoated tablet formulation under fasted (without eating or
drinking) conditions in healthy male participants.